Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Mercury NZ (MCY) / HY26

EBITDAF up 28.5% on revenue down 5.2% as margin hit upper edge

NPAT swung from a NZ$67.0m loss to a NZ$20.0m profit, but a 35% capex step-up absorbed most of the operating cash uplift.

Energy & Utilities / Integrated gentailer

MCY revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $1.7b, versus $3.5b in FY25.

MCY EBITDAF margin

EBITDAF margin across covered periods.

↗
Loading chart...
  • HY23 MCY: Unprecedented high ebitda margin. 34.7%; 4-period range 23.8% to 32.3%. EBITDA margin: 34.7%, unprecedented high; 4-period mean 27.7%, range 23.8%-32.3%.
  • FY23 MCY: Unprecedented high ebitda margin. 30.8%; 4-period range 22.5% to 26.6%. EBITDA margin: 30.8%, unprecedented high; 4-period mean 24.3%, range 22.5%-26.6%.
  • HY25 MCY: Unprecedented low ebitda margin. 23.8%; 4-period range 27% to 34.7%. EBITDA margin: 23.8%, unprecedented low; 4-period mean 30.4%, range 27.0%-34.7%.
  • FY25 MCY: Outside range low ebitda margin. 22.5%; 4-period range 22.6% to 30.8%. EBITDA margin: 22.5%, below normal range; 4-period mean 26.4%, range 22.6%-30.8%.
EBITDA margin: 22.5%, below normal range; 4-period mean 26.4%, range 22.6%-30.8%.

MCY operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $351m, versus $483m in FY25.

MCY working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • FY22 MCY: Unprecedented high operating working-capital movement. $258m; 4-period range $-105m to $180m. Operating working-capital movement: NZ$258.0m, unprecedented high; 2/4 prior periods had builds averaging NZ$127.0m, and 2 had releases averaging NZ$-101.0m.
  • HY24 MCY: Unprecedented high operating working-capital movement. $539m; 4-period range $-17m to $0.1m. Operating working-capital movement: NZ$539.0m, unprecedented high; 2/4 prior periods had builds averaging NZ$0.1m, and 2 had releases averaging NZ$-17.0m.
  • FY25 MCY: Outside range low operating working-capital movement. $-105m; 4-period range $-97m to $258m. Operating working-capital movement: NZ$-105.0m, below normal range; 3/4 prior periods had builds averaging NZ$170.7m, and 1 had releases averaging NZ$-97.0m.
Operating working-capital movement: NZ$-105.0m, below normal range; 3/4 prior periods had builds averaging NZ$170.7m, and 1 had releases averaging NZ$-97.0m.
Release date
24 February 2026
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$1.7b

-5.2% ↓ vs $1.8b

Net profit after tax

$20m

+129.9% ↑ vs −$67m

Net cash inflow from operating activities

$351m

+54.6% ↑ vs $227m

Final dividend per share

10.0c

+4.2% ↑ vs 9.6c

EBITDAF

$537m

+28.5% ↑ vs $418m

Profit before tax

$27m

+128.1% ↑ vs −$96m

Cash and cash equivalents

$73m

-26.3% ↓ vs $99m

Total assets

$9.9b

+3.8% ↑ vs $9.5b

What changed

Operating performance rebounded sharply against a weak HY25 comparable

EBITDAF rose 28.5% to NZ$537.0m on revenue down 5.2% to NZ$1.7b, lifting EBITDAF margin to 32.3% — at the upper edge of the supplied historical range (4-period mean 28.3%). Profit before tax swung from a NZ$96.0m loss to a NZ$27.0m profit (+128.1%), and NPAT swung from a NZ$67.0m loss to NZ$20.0m (+129.9%).

Operating cash flow rose 54.6% to NZ$351.0m, but capex stepped up 35.1% to NZ$273.0m (16.4% of revenue, up from 11.5%), leaving pre-lease free cash flow of NZ$78.0m. Gross borrowings rose NZ$145.0m to NZ$2.3b, yet net debt/EBITDA improved to 4.23x from 5.03x on the higher EBITDAF base. The declared interim dividend is 10.0 cents, up from 9.6 cents.

What matters

Margin recovery on weaker volume is the real read

EBITDAF margin at 32.3% sits above the 4-period mean of 28.3%, while revenue contracted 5.2% (lower edge of the supplied historical range, mean +18.6%). For an integrated gentailer this pattern typically reflects favourable hydrology, generation mix or hedge/yield dynamics rather than customer-volume growth. The release excerpts cite EBITDAF being "supported by above"-average factors but the cut-off text leaves the driver formally unresolved.

The headline growth comes off a loss-making base. PBT and NPAT margins remain at 1.6% and 1.2% — lower edge of historical ranges (means 21.2% and 18.4%). The +128.1% / +129.9% growth percentages reflect a swing from prior losses, not normalised earnings momentum, and ROE remains at 0.4% (lower edge; 4-period mean 4.1%).

Capex intensity stepped up materially. Capex of NZ$273.0m absorbed roughly 78% of operating cash flow, and gross borrowings funded the residual investment despite the better leverage ratio. This matters because the deleveraging headline is driven by EBITDAF mix-shift, not by debt reduction.

Expectations

No stated targets are supplied

The supplied second-half shape shows HY25 captured ~53% of FY25 EBITDAF, implying H2 has historically been the softer half; on that pattern, current EBITDAF momentum would put FY26 well above FY25's NZ$786m, but gentailer half-on-half outcomes are sensitive to hydrology and hedge-cycle factors that the release text does not quantify.

The release flags continued investment in renewables to "meet future demand growth and build resilience". Forward generation, hedge-book and customer-yield context is not provided in the disclosed excerpts, so the durability of the margin uplift cannot be assessed from this filing alone.

Quality of result

Cash conversion at 65.4% (OCF/EBITDAF) is within Annolyse's historical baseline (4-period mean 62.6%; range 54.3%–76.5%) and improved from 54.3% in HY25, when working capital was a drag

Working-capital movement helped: receivable days fell to 44.0 from 45.6, inventory days fell to 10.6 from 13.9, and operating working capital declined NZ$17.0m. So part of the OCF uplift is balance-sheet-assisted rather than purely earnings-driven.

Pre-lease FCF of NZ$78.0m is within the supplied historical range (mean NZ$59.6m). FCF/NPAT of 390% reflects the small NPAT denominator rather than unusual cash strength. Total assets of NZ$9.9b are above Annolyse's historical baseline (4-period mean NZ$6.9b), consistent with the multi-year build phase, and the 35% capex step-up suggests the asset base will continue to expand. Combined with continued borrowings growth, the deleveraging signal rests on EBITDAF holding at this elevated margin.

Unresolved

Open questions

What specifically drove EBITDAF margin to the upper edge — hydrology, hedge gains, generation mix, or sustainable customer yield?
How much of the 54.6% OCF lift reflects underlying earnings versus the NZ$17.0m working-capital release and lower inventory days?
What EBITDAF run-rate is realistic for H2 given current hydrology, hedge book and customer-channel pricing?
When does the renewables capex programme moderate, and what is the expected pre-lease FCF profile during the build?
Is the improved 4.23x leverage durable if EBITDAF margin reverts toward the 28.3% historical mean while gross borrowings continue to rise?

This briefing cannot assess hydrology, hedge-position and forward generation drivers because the disclosed excerpts and calculation pass do not quantify them.

Chat

Ask about MCY HY26

Ask follow-up questions about Mercury NZ's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MCY HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Mercury NZ's HY26 result.

What specifically drove EBITDAF margin to the upper edge — hydrology, hedge gains, generation mix, or sustainable customer yield?Why does "Margin recovery on weaker volume is the real read" matter?How strong was the cash and earnings quality in HY26?What should I watch next for MCY after HY26?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

HY2026 Consolidated Interim Financial Statements

HY26 / financial report↗

HY2026 Financial Results Announcement

HY26 / results announcement↗

HY2026 News Release

HY26 / media release↗

HY2026 Results Presentation

HY26 / results presentation↗

Prior comparable period

HY2025 Financial Results Announcement

HY25 / results announcement↗

HY2025 Interim Report including unaudited financial statements

HY25 / financial report↗

HY2025 News Release

HY25 / media release↗

Full-year context

Integrated report and financial statements

FY25 / financial report↗

News Release

FY25 / results release↗

NZX Results announcement

FY25 / results announcement↗

Related insights

Cross-company views selected from the metrics in this briefing.

Leverage and balance-sheet risk

Net debt / EBITDA is 4.23x, -0.80x versus the prior comparable period.

→

Cash conversion quality

This result converted 65.4% of EBITDA to operating cash flow, +11.1pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 1.7pp.

→

Revenue growth context

Revenue growth was -5.2% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MCY publishes next

Get the next Mercury NZ briefing and related NZX reporting-season updates by email.